OCTAPHARMA is active in the fields of immunology, gynecology, hemophilia and intensive care. They produce immunoglobulins, von Willebrand Factor / Factor VIII concentrates, PPSB concentrate, antithrombin III concentrate, human albumin solution and human plasma.
Octapharma’s main manufacturing site has been in Vienna since 1989 and has been growing rapidly to becoming one of the world’s most advanced plasma fractionation facilities.
With the introduction of a total quality system, additional investments in new production technologies, quality control and IT, the Vienna production facility meets American GMP standards and has been FDA-licensed, since 2004.
In addition to the production facilities, the areas of research and development, clinical research, quality assurance and international approval are located in Vienna. Octapharma uses COOL*SAFE backpacks for their clinical trials.